找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Drug-Induced Oral Complications; Sarah Cousty,Sara Laurencin-Dalicieux Book 2021 Springer Nature Switzerland AG 2021 Drug-induced gingival

[復(fù)制鏈接]
樓主: 外表
31#
發(fā)表于 2025-3-26 22:34:50 | 只看該作者
32#
發(fā)表于 2025-3-27 04:49:38 | 只看該作者
Deji Chen,Mark Nixon,Aloysius Moktibodies inhibiting osteoclastic activity, such as denosumab, and other antiangiogenic cancer drugs..Many risk factors have been identified: duration of the treatment, therapeutic indications, type of bisphosphonate, genetic factors, anatomic factors, dento-alveolar surgery, etc.
33#
發(fā)表于 2025-3-27 06:25:26 | 只看該作者
34#
發(fā)表于 2025-3-27 13:24:34 | 只看該作者
35#
發(fā)表于 2025-3-27 15:25:02 | 只看該作者
Drug-Induced Oral Mucosal Pigmentation,ation and chronic irritation. Different medications, amalgam and other metals may also induce pigmentary modifications in the oral mucosa..Proper diagnosis and treatment of oral pigmentations will help the general dentist manage patients presenting with such lesions.
36#
發(fā)表于 2025-3-27 19:37:02 | 只看該作者
Drug-Induced Oral Lichenoid Reaction,duration of onset of lichenoid lesions varies widely, ranging from 2 weeks to a few months. These lesions generally regress with the suppression of the cause sometimes leaving cheloid type scars in the oral mucosa.
37#
發(fā)表于 2025-3-27 22:32:00 | 只看該作者
Medication-Related Osteonecrosis of the Jaws,tibodies inhibiting osteoclastic activity, such as denosumab, and other antiangiogenic cancer drugs..Many risk factors have been identified: duration of the treatment, therapeutic indications, type of bisphosphonate, genetic factors, anatomic factors, dento-alveolar surgery, etc.
38#
發(fā)表于 2025-3-28 06:03:43 | 只看該作者
39#
發(fā)表于 2025-3-28 06:14:52 | 只看該作者
Book 2021reatments, focusing especially on recently developed therapies. Among the diverse adverse drug reactions covered are gingival overgrowth, ulcerations, lichenoid reactions, pigmentation, and bullous reactions. The potential direct toxic effects on bone of drugs that prevent bone mass loss, such as bi
40#
發(fā)表于 2025-3-28 11:03:29 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 00:03
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
崇明县| 龙胜| 集安市| 泉州市| 海门市| 原平市| 鄯善县| 仁怀市| 富宁县| 瑞昌市| 陇南市| 雅安市| 泰宁县| 阿坝县| 双城市| 隆子县| 依安县| 仪陇县| 康平县| 株洲县| 清丰县| 嘉峪关市| 岳阳县| 石柱| 开化县| 廉江市| 石河子市| 南康市| 荔浦县| 科技| 正镶白旗| 若尔盖县| 宁武县| 赤城县| 苏尼特右旗| 璧山县| 喜德县| 岐山县| 酉阳| 申扎县| 西乡县|